相关实验视频

Updated: May 15, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

BCR:ABL1驱动的慢性髓性白血病的时间和发展轨迹

Aleksandra E Kamizela^1,2,3, Daniel Leongamornlert¹, Nicholas Williams¹

¹Wellcome Sanger Institute, Hinxton, UK.

|April 9, 2025

概括

费城染色体驱动慢性髓性白血病 (CML) 的快速克隆扩张,每年增长率超过70,000%,从诊断前几年开始. 这与大多数癌症的进展速度较慢形成鲜明对比.

科学领域:

血液学
癌症学
遗传学

背景情况:

费城染色体 (BCR:ABL1融合) 是癌症的第一个遗传联系,特别是慢性髓性白血病 (CML).
目前尚不清楚CML的早期发展轨迹,克隆扩张率和疾病进展.

研究的目的:

在CML患者中重建血造干细胞的遗传史.
确定BCR::ABL1克隆扩张率及其与疾病发病的关系.
研究额外突变和端粒长度对CML进展的影响.

主要方法:

从9名CML患者的1,013个造血殖民地进行全基因组测序.
基因树重建以模拟克隆进化
对突变积累,端粒长度和临床时间表的相关性进行分析.

主要成果:

在诊断前3至14年,每年增长率超过70,000%的爆发性BCR:ABL1克隆扩张被推断.
在具有较短端粒的BCR:: ABL1细胞中,突变积累更高.
克隆扩张率与诊断时间相反相关,晚期CML显示进一步的基因组进化.

结论:

BCR:ABL1融合具有强大的致癌能力,导致CML的快速进展.
这种快速的发展轨迹与其他癌症的慢性克隆进化形成鲜明对比.
了解CML的早期动态可以了解癌症发生和疾病进展.

更多相关视频

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...